Viewing Study NCT01439360


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-03-04 @ 10:24 AM
Study NCT ID: NCT01439360
Status: COMPLETED
Last Update Posted: 2018-09-26
First Post: 2011-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10-01
Start Date Type: ACTUAL
Primary Completion Date: 2014-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2014-12-31
Completion Date Type: ACTUAL
First Submit Date: 2011-09-21
First Submit QC Date: None
Study First Post Date: 2011-09-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-12-22
Results First Submit QC Date: None
Results First Post Date: 2017-03-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-08-24
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2018-08-30
Last Update Post Date: 2018-09-26
Last Update Post Date Type: ACTUAL